Geoff Meacham
Stock Analyst at Citigroup
(3.76)
# 711
Out of 4,944 analysts
259
Total ratings
55.28%
Success rate
5.54%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Neutral | $305 → $310 | $284.98 | +8.78% | 13 | Aug 6, 2025 | |
| BIIB Biogen | Maintains: Neutral | $125 → $135 | $128.93 | +4.71% | 15 | Aug 1, 2025 | |
| PTCT PTC Therapeutics | Maintains: Neutral | $40 → $50 | $45.27 | +10.45% | 9 | Jul 28, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $79 → $78 | $56.60 | +37.81% | 3 | Jul 22, 2025 | |
| RPRX Royalty Pharma | Maintains: Buy | $40 → $42 | $35.86 | +17.12% | 3 | Jul 22, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $49.09 | +10.00% | 6 | Jun 25, 2025 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $72 | $54.53 | +32.04% | 1 | Jun 17, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $42 | $25.00 | +68.00% | 1 | Jun 17, 2025 | |
| ACLX Arcellx | Initiates: Buy | $110 | $72.50 | +51.72% | 1 | Jun 17, 2025 | |
| AMLX Amylyx Pharmaceuticals | Initiates: Buy | $12 | $8.20 | +46.34% | 2 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.26 | +217.46% | 4 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $8.48 | -29.25% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $75 | $46.23 | +62.23% | 6 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $650 | $556.56 | +16.79% | 22 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $210 → $205 | $198.64 | +3.20% | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $39.87 | +10.36% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $111.00 | +26.13% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $1.50 | -33.33% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $25.66 | +55.88% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $32.78 | +22.03% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $36.70 | +158.86% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $9.04 | +176.55% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $56.86 | +81.15% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $6.80 | -41.18% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $120.02 | +4.15% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $387.77 | +48.28% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $639.43 | +72.03% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $10.57 | +89.21% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $10.60 | +192.45% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.36 | +2,716.90% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $80.30 | +80.57% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $172.78 | -1.61% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $24.27 | +97.78% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $46.55 | +28.89% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.30 | +515.38% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $4.36 | +221.47% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.47 | +46.25% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.53 | +3,101.51% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $24.65 | +82.56% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.49 | +1,510.74% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $4.18 | -4.31% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.56 | +1,694.87% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.52 | +6,463.71% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $8.51 | +558.05% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $1.79 | +1,855.31% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.28 | +15,896.83% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.44 | +2,816.67% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $8.02 | +149.38% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.52 | +3,764.73% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $4.87 | +84.80% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $8.10 | +640.74% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $3.79 | +84.70% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $13.01 | +76.79% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $81.61 | +0.48% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $301.39 | -68.48% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.81 | +715.49% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $128.89 | +4.74% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $7.54 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.98 | +1,935.62% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $13.47 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $429.93 | -63.25% | 5 | Nov 8, 2017 |
Amgen
Aug 6, 2025
Maintains: Neutral
Price Target: $305 → $310
Current: $284.98
Upside: +8.78%
Biogen
Aug 1, 2025
Maintains: Neutral
Price Target: $125 → $135
Current: $128.93
Upside: +4.71%
PTC Therapeutics
Jul 28, 2025
Maintains: Neutral
Price Target: $40 → $50
Current: $45.27
Upside: +10.45%
CRISPR Therapeutics AG
Jul 22, 2025
Maintains: Buy
Price Target: $79 → $78
Current: $56.60
Upside: +37.81%
Royalty Pharma
Jul 22, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $35.86
Upside: +17.12%
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $49.09
Upside: +10.00%
Protagonist Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $54.53
Upside: +32.04%
NewAmsterdam Pharma Company
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $25.00
Upside: +68.00%
Arcellx
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $72.50
Upside: +51.72%
Amylyx Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $12
Current: $8.20
Upside: +46.34%
Jun 17, 2025
Initiates: Buy
Price Target: $4
Current: $1.26
Upside: +217.46%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $8.48
Upside: -29.25%
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $46.23
Upside: +62.23%
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $556.56
Upside: +16.79%
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $198.64
Upside: +3.20%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $39.87
Upside: +10.36%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $111.00
Upside: +26.13%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $1.50
Upside: -33.33%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $25.66
Upside: +55.88%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $32.78
Upside: +22.03%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $36.70
Upside: +158.86%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $9.04
Upside: +176.55%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $56.86
Upside: +81.15%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $6.80
Upside: -41.18%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $120.02
Upside: +4.15%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $387.77
Upside: +48.28%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $639.43
Upside: +72.03%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $10.57
Upside: +89.21%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $10.60
Upside: +192.45%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.36
Upside: +2,716.90%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $80.30
Upside: +80.57%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $172.78
Upside: -1.61%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $24.27
Upside: +97.78%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $46.55
Upside: +28.89%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.30
Upside: +515.38%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $4.36
Upside: +221.47%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.47
Upside: +46.25%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.53
Upside: +3,101.51%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $24.65
Upside: +82.56%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.49
Upside: +1,510.74%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $4.18
Upside: -4.31%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.56
Upside: +1,694.87%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.52
Upside: +6,463.71%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $8.51
Upside: +558.05%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $1.79
Upside: +1,855.31%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.28
Upside: +15,896.83%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.44
Upside: +2,816.67%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $8.02
Upside: +149.38%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.52
Upside: +3,764.73%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $4.87
Upside: +84.80%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $8.10
Upside: +640.74%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $3.79
Upside: +84.70%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $13.01
Upside: +76.79%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $81.61
Upside: +0.48%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $301.39
Upside: -68.48%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.81
Upside: +715.49%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $128.89
Upside: +4.74%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $7.54
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.98
Upside: +1,935.62%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $13.47
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $429.93
Upside: -63.25%